|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Herpes Simplex Virus 1+2 (HSV) IgG ELISA | IGF-1 ELISA Assay | Pregnenolone ELISA Assay | Ranibizumab (Lucentis®) (mAb-based) ELISA | Tenascin-C Large (FN III-B) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79876 | E20 | IB59107 | TM09034 | 27767 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Herpes Simplex Virus 1+2 (HSV) IgG ELISA is intended for the determination of IgG class antibodies against Herpes Simplex Virus 1+2 (HSV) in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of levels of IGF-I in serum or plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the direct quantitative determination of Pregnenolone in human serum. FDA exempt, for in vitro diagnostic use only. | Enzyme immunoassay for the specific determination of free Ranibizumab in aqueous humour. For research use only - not for use in diagnostic procedures. Not for use in serum or plasma. | Solid phase sandwich ELISA for the determination of Tenascin-C high molecular weight variants including FNâ…¢-B domain in serum, EDTA Plasma, and cell culture supernatant of human, mouse and rat. For research use only, not for use in diagnostic procedures. |
| Detection Target | Varicella-Zoster Virus (VZV) IgG | Alpha-Klotho (Soluble) | Adrenaline | Normetanephrine | CCPlus: Anti-Cyclic Citrullinated |
| Sample Type | Serum, Blood Plasma | Serum, plasma (EDTA, Heparin, Citrate), urine and cell culture supernatant | Blood Plasma, Urine | Urine | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 2 to 50 ng/mL | 0.1 to 25.6 ng/mL | 0 / 10 - 300 ng/mL | 0.20 to 12.5 ng/mL |
| Sensitivity | 100% (95% confidence interval: 98.5% - 100%) | 6.15 pg/mL | Urine: 0.9 ng/mL. Plasma: 0.01 pg/mL. | 23 ng/mL | 0.7 |
| Assay Time | 1 hr, 45 mins (incubation) | 1 hr 45 mins (incubation) | 1 hr 15 mins (incubation) | 2 hour, 15 min. total incubation time. | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |